Loratadine/Pseudoephedrine Sulfate

氯雷他定/硫酸伪麻黄碱

Report date: 2023/11/13 20:04:07

Base Information

Drug NameLoratadine/Pseudoephedrine Sulfate
Drug Alias NamePseudoephedrine/Loratadine氯雷他定硫酸伪麻黄碱Loratadine and Pseudoephedrine氯雷他定伪麻黄碱Loratadine and Pseudoephedrine Sulfate +[12] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsBeta-2 adrenergic receptor agonistsAdrenergic receptors alpha-2 agonists +[6] 
TargetsHistamine H1 receptorBeta-2 adrenergic receptorAdrenergic receptors alpha-1 +[6] 
Therapy Area/IndicationsAnaphylaxisRhinitis, Allergic, SeasonalNasal Obstruction
Global Approved IndicationsRhinitis, Allergic, Seasonal
Approved Indications in ChinaRhinitis, Allergic, Seasonal
Original Approved Country/TerritoryUnited States
Original Approved Date1996/08/23
Country/TerritoryUnited StatesMainland China
CombinationsYes LoratadinePseudoephedrine Sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesSchering - Plough SaBayer Healthcare Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsAnaphylaxisRhinitis, Allergic, SeasonalNasal Obstruction
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksWikipedia